RAPP Rapport Therapeutics, Inc. Common Stock
$39.93
▲ 7.74%
38
Value
14
P/E-17.58
8
P/B4.00
46
P/S72.87
0
EV/EBITDA-11.74
5
Growth
37
Revenue Growth0.0%
28
EPS Growth24.3%
45
FCF Growth-31.0%
41
Momentum
85
12-Month Return284.3%
100
3-Month Return56.3%
100
1-Month Return18.5%
87
RSI (14)50.78
51
50/200 MABullish
75
Profitability
12
ROE-24.8%
46
ROA-21.6%
0
Gross Margin-1.3%
13
Operating Margin-611.0%
0
Net Margin-536.4%
0
FCF Yield-5.5%
0
Risk
34
Beta0.82
75
60-Day Volatility54.8%
0
QScore Analysis